DE60325887D1 - Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen - Google Patents

Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen

Info

Publication number
DE60325887D1
DE60325887D1 DE60325887T DE60325887T DE60325887D1 DE 60325887 D1 DE60325887 D1 DE 60325887D1 DE 60325887 T DE60325887 T DE 60325887T DE 60325887 T DE60325887 T DE 60325887T DE 60325887 D1 DE60325887 D1 DE 60325887D1
Authority
DE
Germany
Prior art keywords
treatment
pharmaceutical compositions
eye diseases
nanoparticles
ophthalmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60325887T
Other languages
English (en)
Inventor
Maria Rosa Gasco
Gian Paolo Zara
Marco Fabrizio Saettone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60325887D1 publication Critical patent/DE60325887D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60325887T 2002-10-31 2003-10-31 Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen Expired - Lifetime DE60325887D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002323A ITMI20022323A1 (it) 2002-10-31 2002-10-31 Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
PCT/EP2003/012180 WO2004039351A2 (en) 2002-10-31 2003-10-31 Pharmaceutical compositions suitable for the treatment of ophthalmic diseases

Publications (1)

Publication Number Publication Date
DE60325887D1 true DE60325887D1 (de) 2009-03-05

Family

ID=32211395

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60325887T Expired - Lifetime DE60325887D1 (de) 2002-10-31 2003-10-31 Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen

Country Status (9)

Country Link
US (1) US20060024374A1 (de)
EP (1) EP1567125B1 (de)
CN (1) CN100594888C (de)
AT (1) ATE420624T1 (de)
AU (1) AU2003301747A1 (de)
CA (1) CA2504199C (de)
DE (1) DE60325887D1 (de)
IT (1) ITMI20022323A1 (de)
WO (1) WO2004039351A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE501766T1 (de) * 2003-05-20 2011-04-15 James F Collins Ophthalmisches arzneimittelabgabesystem
US8012136B2 (en) * 2003-05-20 2011-09-06 Optimyst Systems, Inc. Ophthalmic fluid delivery device and method of operation
US20060182783A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
ITMI20041151A1 (it) * 2004-06-09 2004-09-09 Maria Rosa Gasco Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
EP1674085A1 (de) * 2004-12-22 2006-06-28 Universite Libre De Bruxelles Feste Lipidteilchen als pharmazeutische annehmbare Füllstoffe oder Träger zur Inhalation
WO2007103435A2 (en) * 2006-03-06 2007-09-13 The Regents Of The University Of California Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders
WO2009013563A2 (en) * 2006-11-13 2009-01-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases or disorders of the eye
US20100015218A1 (en) * 2007-02-16 2010-01-21 Vasant Jadhav Compositions and methods for potentiated activity of biologically active molecules
US20090061009A1 (en) * 2007-08-29 2009-03-05 Joseph Schwarz Composition and Method of Treatment of Bacterial Infections
BRPI0821514B8 (pt) * 2007-12-24 2021-05-25 Sun Pharma Advanced Res Co Ltd nanodispersão
US20090212133A1 (en) * 2008-01-25 2009-08-27 Collins Jr James F Ophthalmic fluid delivery device and method of operation
ITMI20090284A1 (it) * 2009-02-26 2010-08-27 Consiglio Nazionale Ricerche Uso di inibitori della serina palmitoiltrasferasi per la prevenzione e il rallentamento delle degenerazioni retiniche ereditarie e relative composizioni
WO2010101989A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
US8778364B2 (en) 2009-06-19 2014-07-15 Sun Pharma Advanced Research Company Ltd. Nanodispersion of a drug and process for its preparation
CA2805426C (en) 2010-07-15 2020-03-24 Corinthian Ophthalmic, Inc. Drop generating device
WO2012009702A1 (en) 2010-07-15 2012-01-19 Corinthian Ophthalmic, Inc. Method and system for performing remote treatment and monitoring
WO2012009696A2 (en) 2010-07-15 2012-01-19 Corinthian Ophthalmic, Inc. Ophthalmic drug delivery
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
RU2460517C1 (ru) * 2011-07-14 2012-09-10 Федеральное государственное учреждение "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Фармацевтическая композиция для комплексного лечения заболеваний глазной поверхности у больных с первичной открытоугольной глаукомой
WO2013090468A1 (en) 2011-12-12 2013-06-20 Corinthian Ophthalmic, Inc. High modulus polymeric ejector mechanism, ejector device, and methods of use
WO2014037498A2 (en) 2012-09-07 2014-03-13 Bracco Imaging Spa Paramagnetic solid lipid nanoparticles (pslns) containing metal amphiphilic complexes for mri.
US9511341B2 (en) 2013-08-30 2016-12-06 Sunny Pharmtech Inc. Method for preparing acetazolamide sodium powder
US20170099833A1 (en) * 2014-05-30 2017-04-13 Oms Investments, Inc. Nano-sized water-based dispersion compositions and methods of making thereof
CA2963872C (en) * 2014-10-09 2023-09-12 Distretto Tecnologico Sicilia Micro E Nano Sistemi S.C.A.R.L. Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
CN111093742B (zh) 2017-06-10 2022-09-16 艾诺维亚股份有限公司 用于处理流体并将流体输送到眼睛的方法和设备
EP4034645A1 (de) 2019-09-23 2022-08-03 Ecole Polytechnique Federale De Lausanne (Epfl) Behandlung und prävention von altersbedingten erkrankungen und/oder von alterung durch hemmung von sphingolipiden

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904649A (en) * 1986-05-23 1990-02-27 New England Medical Center Hospitals, Inc. Method and solution for treating glaucoma
FR2657018A1 (fr) * 1990-01-12 1991-07-19 Merck Sharp & Dohme Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
IT1292142B1 (it) * 1997-06-12 1999-01-25 Maria Rosa Gasco Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
IT1298575B1 (it) * 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
US7153525B1 (en) * 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
US20030072794A1 (en) * 2000-06-09 2003-04-17 Teni Boulikas Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
US6720008B2 (en) * 2002-01-22 2004-04-13 Pr Pharmaceuticals, Inc. Composition and method for the encapsulation of water-soluble molecules into nanoparticles
US7067479B2 (en) * 2002-09-30 2006-06-27 Bausch & Lomb Inc. Compositions with enhanced antimicrobial efficacy against E. coli

Also Published As

Publication number Publication date
EP1567125B1 (de) 2009-01-14
EP1567125A2 (de) 2005-08-31
AU2003301747A8 (en) 2004-05-25
AU2003301747A1 (en) 2004-05-25
ATE420624T1 (de) 2009-01-15
CA2504199A1 (en) 2004-05-13
CN1756529A (zh) 2006-04-05
US20060024374A1 (en) 2006-02-02
CA2504199C (en) 2011-10-18
WO2004039351A3 (en) 2004-07-08
ITMI20022323A1 (it) 2004-05-01
CN100594888C (zh) 2010-03-24
WO2004039351A2 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
DE60325887D1 (de) Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen
DK1385452T3 (da) Anordning til tilförsel af et ophthalmisk medikament
DE60334692D1 (de) Ophthalmologische zubereitung enthaltend roflumilast in der behandlung von krankheiten der augen
BRPI9811989B8 (pt) uso do ácido 9-cis retinóico para a fabricação de um medicamento
WO2002041883A3 (en) As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
AR039130A2 (es) Metodo de administracion de un agente farmaceuticamente activo a un ojo humano
DE50211204D1 (de) Cannabis extrakten pharmazeutische zusammensetzung
CA2440764A1 (en) Combination of brimonidine and timolol for topical ophthalmic use
CA2508303A1 (en) Drug delivery system using subconjunctival depot
BR0206568A (pt) Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição
DE60233898D1 (de) Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin-plasmaspiegeln
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
BR0209063A (pt) Medicamentos e kits de uso medicinal
AU2003290015A1 (en) Mastitis treatment
MA28036A1 (fr) Utilisation d'oxcarbazepine dans le traitement de la douleur liee a la neuropathie diabetique et dans l'amelioration du sommeil
SE0001916D0 (sv) Novel formulation
NO20013605L (no) Preparat for vorter
CA2474703A1 (en) Therapeutic agent of glaucoma comprising bunazosin and prostaglandins
JPH0977656A (ja) 点眼用エアゾル組成物
DE60327249D1 (de) Anthranilsäureamide und ihre pharmazeutische verwendung
JP2002201126A5 (de)
BR122014030158B8 (pt) formulação farmacêutica
RU2002114856A (ru) Способ введения лекарственных препаратов при заболеваниях заднего отрезка глаза
RU2002109353A (ru) Способ лимфотропной терапии больных открытоугольной глаукомой с нормализованным внутриглазным давлением
UA3173U (uk) Спосіб лікування первинної відкритокутової глаукоми

Legal Events

Date Code Title Description
8364 No opposition during term of opposition